Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Inkjet-Printed Imbedded Graphene Nanoplatelet/Zinc Oxide Bulk Heterojunctions Nanocomposite Films for Ultraviolet Photodetection.

Cook B, Gong M, Corbin A, Ewing D, Tramble A, Wu J.

ACS Omega. 2019 Dec 18;4(27):22497-22503. doi: 10.1021/acsomega.9b03173. eCollection 2019 Dec 31.

2.

Genomic Basis of Convergent Island Phenotypes in Boa Constrictors.

Card DC, Adams RH, Schield DR, Perry BW, Corbin AB, Pasquesi GIM, Row K, Van Kleeck MJ, Daza JM, Booth W, Montgomery CE, Boback SM, Castoe TA.

Genome Biol Evol. 2019 Nov 1;11(11):3123-3143. doi: 10.1093/gbe/evz226.

3.

A genome-wide screen identifies IRF2 as a key regulator of caspase-4 in human cells.

Benaoudia S, Martin A, Puig Gamez M, Gay G, Lagrange B, Cornut M, Krasnykov K, Claude JB, Bourgeois CF, Hughes S, Gillet B, Allatif O, Corbin A, Ricci R, Henry T.

EMBO Rep. 2019 Sep;20(9):e48235. doi: 10.15252/embr.201948235. Epub 2019 Jul 29.

PMID:
31353801
4.

The origins and evolution of chromosomes, dosage compensation, and mechanisms underlying venom regulation in snakes.

Schield DR, Card DC, Hales NR, Perry BW, Pasquesi GM, Blackmon H, Adams RH, Corbin AB, Smith CF, Ramesh B, Demuth JP, Betrán E, Tollis M, Meik JM, Mackessy SP, Castoe TA.

Genome Res. 2019 Apr;29(4):590-601. doi: 10.1101/gr.240952.118. Epub 2019 Mar 21.

5.

Ethyl Glucuronide as a Long-term Alcohol Biomarker in Fingernail and Hair. Matrix Comparison and Evaluation of Gender Bias.

Paul R, Tsanaclis L, Murray C, Boroujerdi R, Facer L, Corbin A.

Alcohol Alcohol. 2019 Jul 1;54(4):402-407. doi: 10.1093/alcalc/agz015.

PMID:
30796786
6.

Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins.

Mangeot PE, Risson V, Fusil F, Marnef A, Laurent E, Blin J, Mournetas V, Massouridès E, Sohier TJM, Corbin A, Aubé F, Teixeira M, Pinset C, Schaeffer L, Legube G, Cosset FL, Verhoeyen E, Ohlmann T, Ricci EP.

Nat Commun. 2019 Jan 3;10(1):45. doi: 10.1038/s41467-018-07845-z.

7.

The splicing factor SRSF3 is functionally connected to the nuclear RNA exosome for intronless mRNA decay.

Mure F, Corbin A, Benbahouche NEH, Bertrand E, Manet E, Gruffat H.

Sci Rep. 2018 Aug 27;8(1):12901. doi: 10.1038/s41598-018-31078-1.

8.

Molecular Adaptations for Sensing and Securing Prey and Insight into Amniote Genome Diversity from the Garter Snake Genome.

Perry BW, Card DC, McGlothlin JW, Pasquesi GIM, Adams RH, Schield DR, Hales NR, Corbin AB, Demuth JP, Hoffmann FG, Vandewege MW, Schott RK, Bhattacharyya N, Chang BSW, Casewell NR, Whiteley G, Reyes-Velasco J, Mackessy SP, Gamble T, Storey KB, Biggar KK, Passow CN, Kuo CH, McGaugh SE, Bronikowski AM, de Koning APJ, Edwards SV, Pfrender ME, Minx P, Brodie ED 3rd, Brodie ED Jr, Warren WC, Castoe TA.

Genome Biol Evol. 2018 Aug 1;10(8):2110-2129. doi: 10.1093/gbe/evy157.

9.

Squamate reptiles challenge paradigms of genomic repeat element evolution set by birds and mammals.

Pasquesi GIM, Adams RH, Card DC, Schield DR, Corbin AB, Perry BW, Reyes-Velasco J, Ruggiero RP, Vandewege MW, Shortt JA, Castoe TA.

Nat Commun. 2018 Jul 17;9(1):2774. doi: 10.1038/s41467-018-05279-1.

10.

Cryptic genetic diversity, population structure, and gene flow in the Mojave rattlesnake (Crotalus scutulatus).

Schield DR, Adams RH, Card DC, Corbin AB, Jezkova T, Hales NR, Meik JM, Perry BW, Spencer CL, Smith LL, García GC, Bouzid NM, Strickland JL, Parkinson CL, Borja M, Castañeda-Gaytán G, Bryson RW Jr, Flores-Villela OA, Mackessy SP, Castoe TA.

Mol Phylogenet Evol. 2018 Oct;127:669-681. doi: 10.1016/j.ympev.2018.06.013. Epub 2018 Jun 15.

PMID:
29902574
11.

PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized mice.

Pérès E, Blin J, Ricci EP, Artesi M, Hahaut V, Van den Broeke A, Corbin A, Gazzolo L, Ratner L, Jalinot P, Duc Dodon M.

PLoS Pathog. 2018 Mar 22;14(3):e1006933. doi: 10.1371/journal.ppat.1006933. eCollection 2018 Mar.

12.

Multiparametric Analysis of Myeloid Populations by Flow Cytometry.

Mathie SA, Corbin AL, Eames HL, Udalova IA.

Methods Mol Biol. 2018;1745:113-124. doi: 10.1007/978-1-4939-7680-5_7.

PMID:
29476466
13.

ThetaMater: Bayesian estimation of population size parameter θ from genomic data.

Adams RH, Schield DR, Card DC, Corbin A, Castoe TA.

Bioinformatics. 2018 Mar 15;34(6):1072-1073. doi: 10.1093/bioinformatics/btx733.

PMID:
29194472
14.

Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease.

LeWitt PA, Pahwa R, Sedkov A, Corbin A, Batycky R, Murck H.

J Aerosol Med Pulm Drug Deliv. 2018 Jun;31(3):155-161. doi: 10.1089/jamp.2016.1354. Epub 2017 Nov 21.

15.

Endothelium-derived extracellular vesicles promote splenic monocyte mobilization in myocardial infarction.

Akbar N, Digby JE, Cahill TJ, Tavare AN, Corbin AL, Saluja S, Dawkins S, Edgar L, Rawlings N, Ziberna K, McNeill E; Oxford Acute Myocardial Infarction (OxAMI) Study, Johnson E, Aljabali AA, Dragovic RA, Rohling M, Belgard TG, Udalova IA, Greaves DR, Channon KM, Riley PR, Anthony DC, Choudhury RP.

JCI Insight. 2017 Sep 7;2(17). pii: 93344. doi: 10.1172/jci.insight.93344. eCollection 2017 Sep 7.

16.

The NS1 Protein from Influenza Virus Stimulates Translation Initiation by Enhancing Ribosome Recruitment to mRNAs.

Panthu B, Terrier O, Carron C, Traversier A, Corbin A, Balvay L, Lina B, Rosa-Calatrava M, Ohlmann T.

J Mol Biol. 2017 Oct 27;429(21):3334-3352. doi: 10.1016/j.jmb.2017.04.007. Epub 2017 Apr 20.

PMID:
28433538
17.

Phylogeographic and population genetic analyses reveal multiple species of Boa and independent origins of insular dwarfism.

Card DC, Schield DR, Adams RH, Corbin AB, Perry BW, Andrew AL, Pasquesi GI, Smith EN, Jezkova T, Boback SM, Booth W, Castoe TA.

Mol Phylogenet Evol. 2016 Sep;102:104-16. doi: 10.1016/j.ympev.2016.05.034. Epub 2016 May 27.

18.

Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci.

Philippe C, Vargas-Landin DB, Doucet AJ, van Essen D, Vera-Otarola J, Kuciak M, Corbin A, Nigumann P, Cristofari G.

Elife. 2016 Mar 26;5. pii: e13926. doi: 10.7554/eLife.13926.

19.

Depression and frailty in later life: a systematic review.

Vaughan L, Corbin AL, Goveas JS.

Clin Interv Aging. 2015 Dec 15;10:1947-58. doi: 10.2147/CIA.S69632. eCollection 2015. Review.

20.

Interferon regulatory factor 5 in human autoimmunity and murine models of autoimmune disease.

Eames HL, Corbin AL, Udalova IA.

Transl Res. 2016 Jan;167(1):167-82. doi: 10.1016/j.trsl.2015.06.018. Epub 2015 Jul 4. Review.

PMID:
26207886
21.

A pilot study: retention of adults experiencing homelessness and feasibility of a CDSM diabetes program.

Savage C, Xu Y, Richmond MM, Corbin A, Falciglia M, Gillespie G.

J Community Health Nurs. 2014;31(4):238-48. doi: 10.1080/07370016.2014.958406.

PMID:
25356993
22.

KIT signaling governs differential sensitivity of mature and primitive CML progenitors to tyrosine kinase inhibitors.

Corbin AS, O'Hare T, Gu Z, Kraft IL, Eiring AM, Khorashad JS, Pomicter AD, Zhang TY, Eide CA, Manley PW, Cortes JE, Druker BJ, Deininger MW.

Cancer Res. 2013 Sep 15;73(18):5775-86. doi: 10.1158/0008-5472.CAN-13-1318. Epub 2013 Jul 25.

23.

Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic system.

Brown AN, McSharry JJ, Adams JR, Kulawy R, Barnard RJ, Newhard W, Corbin A, Hazuda DJ, Louie A, Drusano GL.

Antimicrob Agents Chemother. 2012 Mar;56(3):1170-81. doi: 10.1128/AAC.05383-11. Epub 2011 Dec 12.

24.

The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

O'Hare T, Zabriskie MS, Eide CA, Agarwal A, Adrian LT, You H, Corbin AS, Yang F, Press RD, Rivera VM, Toplin J, Wong S, Deininger MW, Druker BJ.

Blood. 2011 Nov 10;118(19):5250-4. doi: 10.1182/blood-2011-05-349191. Epub 2011 Sep 8.

25.

Antimicrobial penetration and efficacy in an in vitro oral biofilm model.

Corbin A, Pitts B, Parker A, Stewart PS.

Antimicrob Agents Chemother. 2011 Jul;55(7):3338-44. doi: 10.1128/AAC.00206-11. Epub 2011 May 2.

26.

Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity.

Corbin AS, Agarwal A, Loriaux M, Cortes J, Deininger MW, Druker BJ.

J Clin Invest. 2011 Jan;121(1):396-409. doi: 10.1172/JCI35721. Epub 2010 Dec 13. Erratum in: J Clin Invest. 2011 Mar 1;121(3):1222.

27.

One institution's experience in implementing protocols for glycemic management.

Corbin AE, Carmical D, Goetz JA, Gadomski VO, Knochelmann C, Whitmer K, Falciglia M.

Dimens Crit Care Nurs. 2010 Jul-Aug;29(4):167-72. doi: 10.1097/DCC.0b013e3181de98da.

PMID:
20543619
28.

Optimized low-level liquid scintillation spectroscopy of 35S for atmospheric and biogeochemical chemistry applications.

Brothers LA, Dominguez G, Abramian A, Corbin A, Bluen B, Thiemens MH.

Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5311-6. doi: 10.1073/pnas.0901168107. Epub 2010 Mar 8.

29.

AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.

O'Hare T, Shakespeare WC, Zhu X, Eide CA, Rivera VM, Wang F, Adrian LT, Zhou T, Huang WS, Xu Q, Metcalf CA 3rd, Tyner JW, Loriaux MM, Corbin AS, Wardwell S, Ning Y, Keats JA, Wang Y, Sundaramoorthi R, Thomas M, Zhou D, Snodgrass J, Commodore L, Sawyer TK, Dalgarno DC, Deininger MW, Druker BJ, Clackson T.

Cancer Cell. 2009 Nov 6;16(5):401-12. doi: 10.1016/j.ccr.2009.09.028.

30.

A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice.

Johnson KJ, Griswold IJ, O'Hare T, Corbin AS, Loriaux M, Deininger MW, Druker BJ.

PLoS One. 2009 Oct 13;4(10):e7439. doi: 10.1371/journal.pone.0007439.

31.

A national prevalence study of pressure ulcers in French hospital inpatients.

Barrois B, Labalette C, Rousseau P, Corbin A, Colin D, Allaert F, Saumet JL.

J Wound Care. 2008 Sep;17(9):373-6, 378-9.

PMID:
18833894
32.

Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease.

Agarwal A, Bumm TG, Corbin AS, O'Hare T, Loriaux M, VanDyke J, Willis SG, Deininger J, Nakayama KI, Druker BJ, Deininger MW.

Blood. 2008 Sep 1;112(5):1960-70. doi: 10.1182/blood-2007-09-113860. Epub 2008 Jun 17.

33.

An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia.

Agarwal A, Eide CA, Harlow A, Corbin AS, Mauro MJ, Druker BJ, Corless CL, Heinrich MC, Deininger MW.

Leukemia. 2008 Dec;22(12):2269-72. doi: 10.1038/leu.2008.124. Epub 2008 May 29. No abstract available.

PMID:
18509354
34.

SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib.

O'Hare T, Eide CA, Tyner JW, Corbin AS, Wong MJ, Buchanan S, Holme K, Jessen KA, Tang C, Lewis HA, Romero RD, Burley SK, Deininger MW.

Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5507-12. doi: 10.1073/pnas.0800587105. Epub 2008 Mar 26.

35.

Improving health status of homeless patients at a nurse-managed clinic in the Midwest USA.

Savage CL, Lindsell CJ, Gillespie GL, Lee RJ, Corbin A.

Health Soc Care Community. 2008 Sep;16(5):469-75. doi: 10.1111/j.1365-2524.2007.00758.x. Epub 2008 Feb 4.

PMID:
18266719
36.

Direct visualization of spatial and temporal patterns of antimicrobial action within model oral biofilms.

Takenaka S, Trivedi HM, Corbin A, Pitts B, Stewart PS.

Appl Environ Microbiol. 2008 Mar;74(6):1869-75. doi: 10.1128/AEM.02218-07. Epub 2008 Jan 25.

37.

[Revisiting HIV-1 assembly].

Corbin A, Grigorov B, Roingeard P, Darlix JL, Muriaux D.

Med Sci (Paris). 2008 Jan;24(1):49-55. doi: 10.1051/medsci/200824149. French.

38.

RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia.

Tyner JW, Walters DK, Willis SG, Luttropp M, Oost J, Loriaux M, Erickson H, Corbin AS, O'Hare T, Heinrich MC, Deininger MW, Druker BJ.

Blood. 2008 Feb 15;111(4):2238-45. Epub 2007 Nov 19.

39.

Budvicia aquatica sepsis in an immunocompromised patient following exposure to the aftermath of Hurricane Katrina.

Corbin A, Delatte C, Besson S, Guidry A, Hoffmann AH 3rd, Monier P, Nathaniel R.

J Med Microbiol. 2007 Aug;56(Pt 8):1124-5.

PMID:
17644725
40.
41.

Characterization of murine JAK2V617F-positive myeloproliferative disease.

Bumm TG, Elsea C, Corbin AS, Loriaux M, Sherbenou D, Wood L, Deininger J, Silver RT, Druker BJ, Deininger MW.

Cancer Res. 2006 Dec 1;66(23):11156-65.

42.

Health care needs of homeless adults at a nurse-managed clinic.

Savage CL, Lindsell CJ, Gillespie GL, Dempsey A, Lee RJ, Corbin A.

J Community Health Nurs. 2006 Winter;23(4):225-34.

PMID:
17064232
43.

Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.

Griswold IJ, MacPartlin M, Bumm T, Goss VL, O'Hare T, Lee KA, Corbin AS, Stoffregen EP, Smith C, Johnson K, Moseson EM, Wood LJ, Polakiewicz RD, Druker BJ, Deininger MW.

Mol Cell Biol. 2006 Aug;26(16):6082-93.

44.

Velopharyngeal anatomy in 22q11.2 deletion syndrome: a three-dimensional cephalometric analysis.

Ruotolo RA, Veitia NA, Corbin A, McDonough J, Solot CB, McDonald-McGinn D, Zackai EH, Emanuel BS, Cnaan A, LaRossa D, Arens R, Kirschner RE.

Cleft Palate Craniofac J. 2006 Jul;43(4):446-56.

45.

Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.

Nguyen TK, Rahmani M, Gao N, Kramer L, Corbin AS, Druker BJ, Dent P, Grant S.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2239-47.

46.

Establishment of a murine model of aggressive systemic mastocytosis/mast cell leukemia.

Demehri S, Corbin A, Loriaux M, Druker BJ, Deininger MW.

Exp Hematol. 2006 Mar;34(3):284-8.

PMID:
16543062
47.

Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.

Schittenhelm MM, Shiraga S, Schroeder A, Corbin AS, Griffith D, Lee FY, Bokemeyer C, Deininger MW, Druker BJ, Heinrich MC.

Cancer Res. 2006 Jan 1;66(1):473-81.

48.

Targeted CML therapy: controlling drug resistance, seeking cure.

O'Hare T, Corbin AS, Druker BJ.

Curr Opin Genet Dev. 2006 Feb;16(1):92-9. Epub 2005 Dec 15. Review.

PMID:
16343892
49.

Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells.

Chuah C, Barnes DJ, Kwok M, Corbin A, Deininger MW, Druker BJ, Melo JV.

Leukemia. 2005 Nov;19(11):1896-904.

PMID:
16167056
50.

A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib.

Crossman LC, O'Hare T, Lange T, Willis SG, Stoffregen EP, Corbin AS, O'Brien SG, Heinrich MC, Druker BJ, Middleton PG, Deininger MW.

Leukemia. 2005 Nov;19(11):1859-62.

PMID:
16151465

Supplemental Content

Loading ...
Support Center